These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15804707

  • 1. Anti-scl-70.
    Basu D, Reveille JD.
    Autoimmunity; 2005 Feb; 38(1):65-72. PubMed ID: 15804707
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-Scl-70 antibodies in systemic scleroderma].
    Le Thi Huong, Sauvaget F, Johanet C, De Gennes C, Raguin G, Abuaf N, Blétry O, Guillevin L, Homberg JC, Godeau P.
    Ann Dermatol Venereol; 1990 Feb; 117(2):103-7. PubMed ID: 2111650
    [Abstract] [Full Text] [Related]

  • 4. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
    Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH.
    J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunological markers of the subsets of systemic scleroderma and its overlap.
    Jabłońska S, Błaszczyk M, Jarzabek-Chorzelska M, Chorzelski T, Kołacińska-Strasz Z.
    Arch Immunol Ther Exp (Warsz); 1991 Oct; 39(4):381-90. PubMed ID: 1821614
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
    Van Praet JT, Van Steendam K, Smith V, De Bruyne G, Mimori T, Bonroy C, Elewaut D, Deforce D, De Keyser F.
    Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
    Bonroy C, Smith V, Van Steendam K, Van Praet J, Deforce D, Devreese K, De Keyser F.
    Clin Exp Rheumatol; 2012 Jul; 30(5):748-55. PubMed ID: 22765957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.
    Spencer-Green G, Alter D, Welch HG.
    Am J Med; 1997 Sep; 103(3):242-8. PubMed ID: 9316557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L, Blockmans D, Verschueren P, Westhovens R, De Beéck KO, Vermeersch P, Van den Bergh K, Burlingame RW, Mahler M, Bossuyt X.
    Clin Chim Acta; 2010 Jul 04; 411(13-14):965-71. PubMed ID: 20346932
    [Abstract] [Full Text] [Related]

  • 17. Anti-Jo-1 antibodies.
    Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A.
    Autoimmunity; 2005 Feb 04; 38(1):73-8. PubMed ID: 15804708
    [Abstract] [Full Text] [Related]

  • 18. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A, Pilar Simeón-Aznar C, Fonollosa-Pla V, Alonso-Vila S, Reverte-Vinaixa MM, Muñoz X, Pallisa E, Selva-O'allaghan A, Fernández-Codina A, Vilardell-Tarrés M.
    Semin Arthritis Rheum; 2014 Dec 04; 44(3):331-7. PubMed ID: 25110305
    [Abstract] [Full Text] [Related]

  • 19. [The Scl-70 antibody and its clinical significance].
    Kühn G, Jarzabek-Chorzelska M, Blaszczyk M, Kolacinska-Strasz Z, Chorzelski TP, Jablonska S.
    Dermatol Monatsschr; 1989 Dec 04; 175(3):133-47. PubMed ID: 2653887
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.